Michele Tana is a Gastroenterology physician affiliated with San Francisco General Hospital. OpenAlex indexes 73 publications with 774 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1001 Potrero Ave # 3d
San Francisco General Hospital, Gastroenterology
San Francisco, CA 941103518
Telephone
415-730-9086Provider last certified this registry record 11 May 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
56.7%Bile Acid56.7%Ursodiol100%Part D<11 patientsCancer & immunology
43.3%Purine Antimetabolite43.3%Azathioprine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2021 per NIH RePORTER. The latest:
- A Multiomic Search for Antigens in Autoimmune Hepatitis
University of California, San Francisco
FY2021$242,250R21DK127275 - A Multiomic Search for Antigens in Autoimmune Hepatitis
University of California, San Francisco
FY2020$201,875R21DK127275
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immune profiling links autoimmune hepatitis to human herpesvirus 6 and relaxin receptor antigens
The Journal of Experimental Medicine
2026 - Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated Cirrhosis
Clinical Gastroenterology and Hepatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Deeks, MD
San Francisco General Hospital
Geoffrey Manley, MD, PhD
San Francisco General Hospital
Francesca Delling, MD
San Francisco General Hospital
Melvin Cheitlin, MD
San Francisco General Hospital
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”